rmi 12330a has been researched along with vasoactive intestinal peptide in 4 studies
| Studies (rmi 12330a) | Trials (rmi 12330a) | Recent Studies (post-2010) (rmi 12330a) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 141 | 0 | 24 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcalde, AI; Arruebo, MP; Murillo, MD; RodrÃguez-Yoldi, MJ | 1 |
| Chu, MM; Lee, EK; Lin, HR; Wong, AO; Xiao, D | 1 |
| Becq-Giraudon, L; Goursaud, S; Gressens, P; Janet, T; Muller, JM; Pineau, N | 1 |
| Azuma, M; Matsuda, K; Nejigaki, Y; Shioda, S; Takahashi, A; Tanaka, M; Uchiyama, M | 1 |
4 other study(ies) available for rmi 12330a and vasoactive intestinal peptide
| Article | Year |
|---|---|
Influence of VIP on D-galactose transport across rabbit jejunum in vivo.
Topics: Animals; Galactose; Imines; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Rabbits; Time Factors; Vasoactive Intestinal Peptide | 1988 |
Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Carps; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activators; Enzyme Inhibitors; Growth Hormone; Imines; In Vitro Techniques; Ionophores; Isoquinolines; Neuropeptides; Neurotransmitter Agents; Nifedipine; Phosphodiesterase Inhibitors; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Signal Transduction; Sulfonamides; Vasoactive Intestinal Peptide | 2002 |
Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Analysis of Variance; Blotting, Southern; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Humans; Imines; Iodine Isotopes; Lymphoma; Peptide Fragments; Peptide PHI; Pertussis Toxin; Protein Binding; Radioligand Assay; Receptors, Cell Surface; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Vasoactive Intestinal Peptide | 2005 |
Pituitary adenylate cyclase-activating polypeptide induces somatolactin release from cultured goldfish pituitary cells.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Calmodulin; Cells, Cultured; Enzyme Inhibitors; Estrenes; Female; Fish Proteins; Glycoproteins; Goldfish; Growth Substances; Imidazoles; Imines; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Maleimides; Phosphoinositide Phospholipase C; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Pituitary Hormones; Protein Kinase C; Pyrrolidinones; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Signal Transduction; Sulfonamides; Vasoactive Intestinal Peptide | 2009 |